Blake Aftab Ph.D.

497 posts

Blake Aftab Ph.D.

@blake_aftab

Chief Scientific Officer @AdicetBio. #CART #TcellRx #TCR #gammadelta #immunotherapy ... Tweets are my own; retweets are not endorsements

California, USA Katılım Eylül 2010

144 Takip Edilen210 Takipçiler

Blake Aftab Ph.D. retweetledi

Sriganesh Srihari | Biomedical Data Science@srigsri23·14 May

Dear biologists, what would you be willing to pay for this service?👇 If you've got raw RNAseq data - can be 10 or can be a 1,000 samples, then we can provide a comprehensive analysis of the data in real fast time, like within 2-3 days. Details 👇

English

12.5K

Blake Aftab Ph.D.@blake_aftab·13 Nis

@jhupharmacology @lindemilesphd @RieWeb20 50% are also UAD Research alum too!

English

Johns Hopkins Pharmacology@jhupharmacology·12 Nis

50% of this panel is Pharmacology alumni, so you know it will be good! @lindemilesphd and @RieWeb20

English

882

Blake Aftab Ph.D. retweetledi

AdicetBio@AdicetBio·4 Mar

We are pleased to announce Shon Green, Ph.D, as our new Vice President of Nonclinical Development! Shon will play a crucial role as we advance our novel pipeline of CAR and CAd gamma delta T cell therapies. #biotechnology #celltherapy #CART #oncology

GIF

English

780

Blake Aftab Ph.D. retweetledi

Blood Journals Portfolio@BloodPortfolio·23 Şub

The latest issue of Blood is now available featuring a new review series on banked allogeneic immune effector cells. Also, a bonus podcast episode discussing the series with Associate Editor Dr. Helen Heslop and author Dr. Jeffery Miller. loom.ly/p1Ds0qA

English

7.6K

Blake Aftab Ph.D. retweetledi

Rajiv Khanna@khanna_rajiv·27 Oca

Please RT. Abstract submission for APVIC 2023 meeting is due by Feb 15. Don't forget register for the meeting as well. You can see more details on apvic.org @APVICongress @ASImmunology @QIMRBerghofer @WEHI_research @TheDohertyInst @TRI_info @ClinTransImmuno

English

1.8K

Blake Aftab Ph.D. retweetledi

Rajiv Khanna@khanna_rajiv·12 Oca

Registration and abstract submission for Asia Pacific Vaccine and Immunotherapy Congress is open apvic.org Amazing list of speakers: apvic.org/invited-speake… @QIMRBerghofer @ClinTransImmuno @ASImmunology @TRI_info @YUmmunology @MelbImmunoNet @UQ_News @TheDohertyInst

English

828

Blake Aftab Ph.D. retweetledi

Clinical & Translational Immunology@ClinTransImmuno·30 Kas

Best of @ClinTransImmuno at #ASI2022Mel first up is @K_P_Nishimoto @AdicetBio describing their study published- 'Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models.' onlinelibrary.wiley.com/doi/10.1002/ct… @ASImmunology

Clinical & Translational Immunology tweet media

English

Blake Aftab Ph.D.@blake_aftab·11 Kas

Couldn't be more proud of our scientists and our #team for what they are accomplishing with the strength of their science. #sitc2022

AdicetBio@AdicetBio

Congratulations to Marissa Herrman & the Adicet research team for being selected as this year’s @jitcancer Best Immune Cell Therapies and Immune Cell Engineering Paper! Your commitment to developing transformative therapies to defeat cancer is inspiring! #celltherapy #SITC2022

English

Blake Aftab Ph.D. retweetledi

AdicetBio@AdicetBio·10 Kas

Join us tomorrow (Thursday, Nov 10 at 9:00 a.m. ET) for our R&D Day where we’ll be unveiling details on four new highly differentiated CAR and CAd pipeline candidates! Live Webcast link in Investor “Presentations & Events” section at adicetbio.com.

GIF

English

Blake Aftab Ph.D. retweetledi

AdicetBio@AdicetBio·8 Kas

Adicet is excited to be on the ground @sitcancer kicking off today in Boston! We’re presenting preclinical data and unveiling 4 new highly differentiated CAR (chimeric antigen receptor) and CAd (chimeric adaptor) pipeline programs targeting several heme and solid malignancies.

GIF

English

Blake Aftab Ph.D. retweetledi

Blood Advances@BloodAdvances·31 Eki

Early use of third-party virus-specific T-cells is safe and leads to high rates of viral control and excellent outcomes in HSCT. loom.ly/eW36rVY #immunobiologyandimmunotherapy

English

Blake Aftab Ph.D. retweetledi

AdicetBio@AdicetBio·20 Ağu

As our pipeline progresses, we expanded into a new state-of-the-art facility! We look forward to calling this home as we live our mission to deliver best-in-class gamma delta T cell therapies for patients fighting cancer! #Adicetlife #greatplacetowork #celltherapy #biotechnology

English

Blake Aftab Ph.D. retweetledi

Chen Schor@ChenSchor·5 Tem

Presence of gamma-delta1 T cells is strongly associated with survival of patients with Non-Small Cell Lung Cancer and several additional solid tumors. Check recent nature cancer publication June 2022.

English

Blake Aftab Ph.D. retweetledi

Rajiv Khanna@khanna_rajiv·30 Haz

Another reminder for upcoming ANZ ISCT meeting in Brisbane on Aug 4-5, 2022. Check this link for more details: bit.ly/3a0AmJs @ISCTglobal @celltherapynews @celltherapyblog @CellTherapies_ @ZlatiborVelick1 @EmilyBlyth5 @jmacpher @ngaire_elwood @KlamerGuy

English

Blake Aftab Ph.D. retweetledi

AdicetBio@AdicetBio·17 Haz

We’re celebrating #pride at @Adicet and recognizing the important role the LGBTQ+ community has played in building diverse, inclusive and supportive communities. There is more work to be done and we continue to listen, learn and support advances in #diversityandinclusion.

GIF

English

Blake Aftab Ph.D. retweetledi

Linde Miles@lindemilesphd·17 Haz

The Miles lab is hiring and our first job post is live!! We are looking for an excited, passionate research assistant to join our new team. Please retweet and share with anyone interested!

jobRxiv@jobRxiv

Research Assistant II/III/IV – Linde Miles Lab (@lindemilesphd) Cincinnati Children's Hospital Medical Center (@CincyChildrens) - The Miles Lab - USA jobrxiv.org/job/cincinnati… #ScienceJobs

English

Blake Aftab Ph.D. retweetledi

Nasdaq Exchange@NasdaqExchange·10 Haz

We're closing the day at the @NasdaqExchange with @AdicetBio! 🧬 $ACET is a clinical stage biotechnology company discovering and developing allogeneic gamma-delta T cell therapies for cancer.

English

Blake Aftab Ph.D. retweetledi

AdicetBio@AdicetBio·10 Haz

On the heels of an exciting ASCO where we presented additional positive data on ADI-001, the team rang the closing bell at NASDAQ today!! It’s an honor to see so many inspired by our mission to deliver best-in-class gamma-delta T cell therapies for patients fighting cancer.

Nasdaq Exchange@NasdaqExchange

We're closing the day at the @NasdaqExchange with @AdicetBio! 🧬 $ACET is a clinical stage biotechnology company discovering and developing allogeneic gamma-delta T cell therapies for cancer.

English

Keşfet

@jhupharmacology @lindemilesphd @APVICongress @ASImmunology @WEHI_research @TheDohertyInst @TRI_info @ClinTransImmuno